Related Experiment Video
Updated: May 7, 2026

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
Published on: February 27, 2017
Autologous blood patch for persistent air leak in children
Joseph B Lillegard1, Raelene D Kennedy, Michael B Ishitani
1Division of Pediatric Surgery, Department of Surgery, Mayo Clinic, SW, Rochester, MN 55905, USA.
Insights
Autologous blood patch (ABP) is a safe and effective treatment for persistent air leak (PAL) in children. This novel approach offers an inexpensive, simple method to seal air leaks, avoiding toxic chemicals.
Area of Science:
- Pediatric Thoracic Surgery
- Pulmonary Medicine
- Critical Care Medicine
Background:
- Persistent air leak (PAL) is a significant complication in pediatric patients, associated with increased morbidity.
- Current treatments like chemical or mechanical pleurodesis have unknown long-term effects in children.
- Autologous blood patch (ABP) presents a novel therapeutic alternative.
Purpose of the Study:
- To evaluate the efficacy and safety of autologous blood patch (ABP) for treating persistent air leak (PAL) in pediatric patients.
- To assess the outcomes and complications associated with ABP in children.
- To determine the feasibility of ABP as a treatment for PAL in the pediatric population.
Main Methods:
- Eight children aged 2 months to 18 years with PAL were treated using ABP.
- A fresh whole blood sample was obtained from each patient and injected via their existing chest tube.
- Data on blood volume injected, air leak cessation time, chest tube removal, outcomes, and complications were retrospectively reviewed.
Main Results:
- Successful air leak cessation was achieved in all eight pediatric patients treated with ABP.
- Three patients experienced immediate air leak seal, two sealed within 1-2 days, and three required a second ABP for immediate seal.
- Chest tubes were removed within 2-3 days in seven patients; one developed a transient asymptomatic pneumothorax.
Conclusions:
- Autologous blood patch (ABP) is a safe and effective treatment for persistent air leak (PAL) in children.
- ABP is an inexpensive and easily performed procedure, avoiding the use of toxic chemicals for pleurodesis.
- This technique offers a promising alternative for managing PAL in pediatric patients.
Purpose:
Persistent air leak (PAL) is associated with increased morbidity. Standard treatment of PAL includes chemical or mechanical pleurodesis. Long-term impact of these interventions is not known in the pediatric population. Autologous blood patch (ABP) offers a novel treatment option. We report our experience with autologous blood patch to successfully treat PAL in eight children.
Methods:
Children with PAL were treated with ABP. A fresh whole blood sample was obtained from each patient and injected via their pre-existing chest tube. Volume of blood injected, time to cessation of air leak, time to chest tube removal, outcomes and complications were reviewed.
Results:
Eight children aged 2 months to 18 years underwent ABP. Three children had immediate seal of air leak, while two patients sealed after 1 and 2 days. Three patients required a second ABP, after which they had immediate seal of air leak. Chest tubes were removed within 2-3 days in 7 cases. One child developed an asymptomatic pneumothorax and required 8 days for radiographic resolution.
Conclusion:
ABP appears to be a safe and effective treatment option for PAL in children. ABP offers an inexpensive, easy to perform technique and avoids use of toxic chemicals for pleurodesis in pediatric patients.
Related Concept Videos
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Cardiopulmonary Resuscitation II: ACLS Airway Management
